CompoAtlas

Bronchosirum Échinacée avec Astragale

Natural health product licensed in Canada

Other names
Bronchosirum Échinacée +, Bronchosirum Échinacée - Astragale, Bronchosirum Échinacée Plus
Licence holder
Bronchosirum Inc.
NPN or DIN-HM
80108975
Status
Active licence
Licence date
30 March 2021
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Echinacée purpurea

Source : Racine

Extract : Matériel brut sec

Extraction ratio : 5:1

Dry plant equivalent : 1,000 mg

200 mgNot calculated
Astragalus membranaceus

Source : Racine

40 mgNot calculated
L-Lysine

Source : L-Lysine

30 mgNot calculated
Ganoderma lucidum

Source : Mycélium

20 mgNot calculated
Lentinula edodes

Source : Mycélium

20 mgNot calculated

Non-medicinal ingredients

Cellulose microcristalline, Amidon de maïs, Hypromellose, Stéarate de magnésium

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years1 Capsule3 Tous les jours

Uses authorised in Canada

Source de polysaccharides fongiques ayant des propriétés immunomodulatrices. Source d'antioxydants/Fournit des antioxydants. Utilisé traditionnellement en phytothérapie pour aider à soulager les symptômes du rhume et des infections des voies respiratoires supérieures. L'échinacée est utilisée traditionnellement en phytothérapie pour aider à soulager les symptômes du rhume et des infections des voies respiratoires supérieures. Le reishi et le shiitaké sont une source d'antioxydants/Fournissent des antioxydants et source de polysaccarides fongiques ayant des propriétés immunomodulatrices.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80108975

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line